Glucosinolates Market is anticipated to grow considerably through 2032, owing to the increasing awareness among consumers regarding the qualities of glucosinolates, such as regulatory functions in phase I metabolism, inflammation, stress response, antioxidant activities, as well as natural antimicrobial properties. In addition, the increasing product demand in cosmetics industry across Europe would further bolster the market growth.

The Brassicaceae family of plants, which includes broccoli, cauliflower, cabbage, rapeseed, mustard, and horseradish, contains glucosinolates and other physiologically active substances. Cruciferous vegetables and other dietary sources that contain glucosinolates are beneficial for enhancing health and protecting against dangerous illnesses like colon cancer, prostate cancer, breast cancer, and myocardial infarction.

Besides, it has been discovered that the breakdown products of glucosinolate, isothiocyanates, and indoles cause apoptosis, decreasing tumor growth by inhibiting the phase 1 enzyme, changing oestrogen metabolism, and obstructing the cell cycle. The compound also boasts of anti-inflammatory properties.

Overall, the glucosinolates industry is segmented in terms of extract and region.

Based on the extract, the food & beverages segment is anticipated to depict over 6% CAGR through 2032. The growth can be attributed to the strong potential that glucosinolates offer in a diet rich in fruits and vegetables that help delay and prevent the onset of chronic diseases such as neurological, cardiometabolic, and musculoskeletal conditions, as well as certain cancers. According to credible reports, glucosinolates have been recognized in preclinical and clinical studies. As per current studies, glucosinolates (and isothiocyanates) act via several mechanisms, eventually exposing anti-inflammatory, antioxidant, and chemo-protective effects.

In addition, sulforaphane glucosinolates is also said to be an antioxidant found in broccoli sprouts, which plays a crucial role in preventing multiple diseases, such as cancer, macular degeneration, high blood pressure, and stomach ulcers.

Regionally, the Europe glucosinolates market is anticipated to be valued at over USD 85 million by 2032 end. The regional market growth can be credited to the rising demand for products in the cosmetics industry. As per Cosmetics Europe statistics, the European cosmetics and personal care market was valued at USD 89.1 billion in 2021. The mounting importance of sulforaphane glucosinolates in skin care formulations would further support the market expansion in the near future.

Needless to mention that various R&D studies around glucosinolates also depict that the compound boasts of the ability to reverse photoaging by protecting against UV-induced skin damage, emerging as a go-to formula for people across the Europe.